STONKWHISPER
← Back to Intel
Insider ActivityKLRA

Bain Capital Life Sciences Investors, LLC, Insider at Kailera Therapeutics, Inc., bought $25.0M of KLRA

Updated Jun 21, 2026
Bain Capital Life Sciences Investors, LLC Insider
Kailera Therapeutics, Inc. · $KLRA
$25.0M Total Value
1,562,500 Shares Traded
$16 Price / Share
22,583,268 Shares Owned After
2026-04-20 Filing Date

Transaction Details

InsiderBain Capital Life Sciences Investors, LLC
TitleInsider
CompanyKailera Therapeutics, Inc.
TickerKLRA
Transaction TypePurchase
Transaction Date2026-04-20
Shares Traded1,562,500
Price Per Share$16
Total Value$25.0M
Filed Date2026-04-20
Accession Number0001193125-26-164389

Ownership Context

Shares Owned After Transaction22,583,268
Ownership TypeIndirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-164389

Other Insider Trades — KLRA

Other Trades by Bain Capital Life Sciences Investors, LLC

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for KLRA — Kailera Therapeutics, Inc. →

Track KLRA insider activity in real time on The Wire →

Get alerts when Bain Capital Life Sciences Investors, LLC files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 21, 2026 at 07:20 UTC

Want real-time data? Access The Wire for live sentiment tracking.